Press Releases

Date	Title
10/1/20	Pulse Biosciences Announces FDA IDE Approval and Initiation of Sebaceous Hyperplasia Study
9/29/20	Pulse Biosciences Announces Receipt of MDSAP Certification
9/15/20	Pulse Biosciences Grants Equity Incentive Awards To New Employees
9/1/20	Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
8/10/20	Pulse Biosciences Reports Second Quarter 2020 Financial Results
8/6/20	Pulse Biosciences, Inc. Appoints Richard van den Broek to Board of Directors
7/27/20	Pulse Biosciences Schedules Second Quarter 2020 Financial Results Conference Call for August 10, 2020
7/1/20	Nano-Pulse Stimulation™ Technology Produces Favorable Results in Several Clinical Studies Presented at the 2020 Laser Medicine and Surgery Virtual Annual Conference
6/16/20	Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering
6/10/20	Pulse Biosciences, Inc. Announces Further Details of Oversubscribed Rights Offering

Keyword Search